HOME Press Releases Vascular Patches Market worth 525.8 Million USD by 2023



Vascular Patches Market worth 525.8 Million USD by 2023


The report "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023", The vascular patches market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%.

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 65 market data Tables and 31 Figures spread through 100 Pages and in-depth TOC on "Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023"
https://www.marketsandmarkets.com/Market-Reports/vascular-patches-market-176813375.html
Early buyers will receive 10% customization on reports.

Growth in the vascular patches market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. The emerging markets are expected to offer a wide range of growth opportunities for players in the market.

On the other hand, product failures and recalls is expected to limit market growth in the coming years. The need for highly skilled professionals may also challenge market growth to a certain extent.

The biologic vascular patch segment accounted for the largest share of the market in 2017

Based on material, the vascular patches market is segmented into biologic vascular patches and synthetic vascular patches. Of all these product segments, biologic vascular patches accounted for the largest share of the market in 2017. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of biologic vascular patches such as superior biocompatibility, ease of use, minimal suture line bleeding, and reduced rates of infection in comparison with synthetic patches.

The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period.

Based on end user, the vascular patches market has been segmented into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period. The growth of this end-user segment is majorly attributed to factors such as the growth in the number of vascular procedures in hospitals and improving healthcare infrastructure in several developing countries across the globe.

North America commanded the largest share of the market in 2017.

Based on region, the vascular patches market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America accounted for the largest share of the vascular patches market. The growing prevalence of vascular diseases and the rising geriatric population in this region as well as the presence of all the major players in this region are the major factors supporting the growth of the vascular patches market in North America.

The major players in the vascular patches market include Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

We will organize an analyst call and demonstrate the latent opportunities and threats which will likely impact your business, at no cost.

Speak to Analyst


* Name :
* Business Email :
* Phone :
* Designation :
* Country:
Report MD 6363: Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023
* Enter the text from the image
   to the textbox :
9 5 4 4 4  
Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports